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Abstract 
This longitudinal observational study examined how individual versus illness belief 
schema compare as predictors of post-stroke recovery. Forty-two stroke survivors (mean 
age=66.9 years/range=29-96 years; 68% male), were involved. The primary outcome, Health-
Related Quality of Life (HRQL) was measured using EQ-5D-5L; mood using Patient Health 
Questionnaire-9; and disability using Nottingham Extended Activities of Daily Living Scale. 
Stroke Illness Perception Questionnaire-Revised measured illness beliefs. Linear regressions 
showed that individual illness beliefs significantly explained more of the variance in three-
month post-stroke recovery than schema (7.4-22.5% versus 1.9-9.9%). Individual versus 
illness belief schema predict outcomes differently, but which approach predicts outcomes better 
remains unclear.  
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Introduction 
The Common Sense Model (CSM) suggests that when confronted with a threat to their 
health, such as the common cold, individuals experience a disequilibrium that they are 
motivated to resolve, and do so by constructing beliefs about their illness and treatment that 
inform what they do to cope and feel better (Leventhal et al., 1980).  
Illness beliefs have five core domains (Leventhal et al., 1980). ‘Identity’ describes 
perceptions about the label of the illness, for example a cold, and associated symptoms (e.g., 
cough sore throat etc.) ‘Timeline’ refers to beliefs about an acute or chronic illness duration. 
‘Consequences’ refer to beliefs about the seriousness of the disease and daily impact (e.g., pain, 
time-off work etc.). ‘Cure/control’ refers to perceptions about the amenability of the illness to 
cure/prevention/ treatment. ‘Causes’ describes views about internal (e.g., genes) or external 
(e.g., a germ or virus)causes of the illness. There is a wealth of evidence supporting these 
domains in a broad range of illnesses, including cancer, hypertension, and diabetes mellitus  
(e.g., Meyer et al. (1985)). These domains have since been extended to include: ‘timeline-
cyclical’ beliefs around an episodic nature of illness; ‘personal control’ and ‘treatment control’ 
beliefs around peoples’ own ability and that of their treatment (e.g., tablets) to manage their 
illness; ‘illness coherence’ beliefs around understanding of the illness; and ‘emotional 
representations’ referring to illness-related distress (Moss-Morris et al., 2002). 
The CSM has been used widely for understanding treatment adherence, mood, and 
recovery in a range of acute and chronic illness groups. The present study focuses on stroke.   
Stroke is an example of a condition where recovery is individual and highly variable 
(Lazar and Antoniello, 2008), and depends upon good patient adherence to complex long-term 
treatments (e.g., medication, lifestyle management and rehabilitation). Post-stroke recovery 
and treatment adherence can be explained in part by non-modifiable socio-demographic (e.g., 
age, income) and clinical variables (e.g., stroke severity, and initial impairment) (Bushnell et 
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al., 2011, Lazar and Antoniello, 2008). However, socio-demographic variables predict 
outcomes very weakly In a longitudinal observational study involving 180 survivors one-year 
post-stroke, O'Carroll et al. (2011) found that modifiable psychological factors (depression and 
treatment beliefs) explain significantly more (around 30%) of the additional variance in 
medication adherence. 
Several systematic reviews and meta-analyses have synthesised the CSM literature to 
examine the relationship of individual illness belief domains with coping/treatment adherence. 
For example, Hagger and Orbell (2003) examined 45 studies across a range of acute and 
chronic conditions, and demonstrated that illness beliefs are inter-related, and these so-called 
illness belief schema are correlated with coping and illness outcomes. These findings were 
recently replicated for individuals with chronic illnesses (Hagger et al., 2017). However, Aujla 
et al. (2016) and Brandes and Mullan (2014) both showed that when examined individually, 
illness belief domains predict adherence to self-management in people with acute or chronic 
physical illnesses very weakly (<0.13).  
Illness belief schema are a key premise of the CSM; they are stored in peoples’ memory 
and help them to understand and respond to situations (Leventhal et al., 1980). There are now 
several studies utilising cluster analysis  to group individuals with physical illnesses according 
to their illness belief schema (e.g., Medley et al. (2010); Lin and Heidrich (2012); and Snell et 
al. (2014)).While these studies have not involved stroke survivors, illness belief schema have 
consistently been shown to predict physical and psychological outcomes, and coping/treatment 
adherence.  
In summary, illness beliefs outlined by the CSM are inter-related and held in schema.  
When examined individually illness beliefs predict outcomes such as adherence, weakly. Aujla 
et al. (2016) argued that the low effect sizes to have emerged in their review have been a result 
of examining the predictive utility of individual CSM components rather than of the model as 
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a whole. Therefore, we posit that individual and illness belief schema are likely to differ in 
their prediction of outcomes, where schema may have greater predictive power. 
A previous study has examined this hypothesis, and showed that individual and illness 
belief schema perform comparably when predicting outcomes in people with type 2 diabetes 
mellitus (Skinner et al., 2011). However, this study did not include all illness belief domains. 
Specifically, treatment control beliefs and emotional representations were excluded; both of 
which are important predictors of post-stroke outcomes after stroke (e.g., mood (Twiddy et al., 
2012) and medication adherence (O'Carroll et al., 2011)). In addition, the authors did not report 
on statistical comparisons between regression models containing individual versus illness 
belief schema (i.e., clusters). For example, goodness of fit, using the change in R2 and 
likelihood ratio test. However, by carrying out these comparisons, one would be able to discern 
how well variables (or groups of variables) in each regression model perform, and therefore 
judge which approach (individual versus illness belief schema) better predicts  (or explains 
more of the variability) in outcome(s). To our knowledge, this analysis has not yet been 
undertaken. 
The present study has three aims. First, to examine whether stroke survivors can be 
grouped according to different illness belief schema. Second, to conduct a preliminary enquiry 
into how individual versus illness belief schema may compare as predictors of three-month 
post-stroke recovery  (Health-Related Quality of Life (HRQL), mood, and disability). Third, 
to explore how much of the additional variability in post-stroke recovery is explained by 
individual versus illness belief schema, over and above that explained by socio-demographic 
and clinical variables. 
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Methods 
Design and Participants 
A longitudinal observational design was employed, and reported in accordance with the 
appropriate guidelines. Data were collected at baseline (after study enrolment) and follow-up 
(three-months post-stroke). Participants were recruited from consecutive admissions to acute 
stroke and rehabilitation wards and from outpatient clinics in one hospital in Nottingham, 
United Kingdom (UK). Inclusion criteria were: adults (>18 years); confirmed diagnosis of 
acute stroke (within 8-weeks); sufficient (English) language and cognitive ability to participate, 
assessed through liaison with the clinical care team and review of medical notes; and written 
informed consent. We excluded individuals involved in psychological intervention studies. 
Ethical approval was granted by the National Research Ethics Service (NRES) Committee East 
Midlands (UK) – Leicester (13/EM/0392).  
We initially collected socio-demographic information, including age, sex, ethnicity, 
education/employment, and social deprivation (using the English Indices of Multiple 
Deprivation (IMD) (Department for Communities and Local Government, 2015)). Medical 
history, including stroke severity (National Institutes of Health Stroke Scale (NIHSS) (Duncan 
et al., 2005));; disability (Modified Rankin Scale (Rankin, 1957) and Barthel Index (Mahoney 
and Barthel, 1965)); and comorbidities was also gathered. In addition, we collected clinical 
information (blood pressure, blood glucose, cholesterol and Body Mass Index (BMI)); family 
history (first-degree relative); and lifestyle data (smoking status, alcohol consumption, physical 
activity and diet). Participants also completed the study measures (elaborated below) at 
baseline and follow-up. Most of the data were self-reported. Clinician-reported data (e.g., 
stroke severity, blood tests and BMI) are collected routinely locally, and were therefore 
extracted from patients’ medical records. 
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Eligibility was assessed in 1085 patients over a 12-month period. Eighty-eight were 
eligible. The main reasons for non-eligibility were: non-stroke diagnosis (N=249); stroke onset 
over 8-weeks before (N=186); and enrolled in other research studies (N=141). Thirty-eight 
people declined, 50 consented; and attrition was 16%. Therefore, we had baseline data from 46 
and follow-up data from 42 participants In brief, average age was 66.9 years (SD=14.5 years; 
range 29-96 years), with 68% male gender and 98% White-British ethnicity. IMD scores 
indicated that participants resided on average among the most deprived 70% of areas in 
England. The majority of participants reported a non-severe first-stroke (78%), and 
experienced low levels of disability and mild depressive symptomatology. 
Measures 
The International Classification of Functioning (ICF) framework for health and disability 
highlights important outcomes to assess in post-stroke recovery: ‘impairments’ – problems or 
loss in body function; ‘activities’ – performance of a task or action; and ‘participation’ – 
involvement in a life situation (World Health Organization, 2001). We selected our outcomes 
according to these domains. The choice of measures was guided by a series of papers (Salter 
et al. (2005a), Salter et al. (2005b), and Salter et al. (2005c)) that synthesised the most 
commonly used instruments across each ICF domain, and critically reviewed their 
psychometric and administrative properties.  
ICF Participation: HRQL  
We measured HRQL using EQ-5D-5L (Brooks, 1996). The first part, termed the 
‘Descriptive System,’ comprises five items assessing Mobility, Self-Care, Usual Activities, 
Pain/Discomfort, and Anxiety/Depression domains of HRQL. Possible responses were “no 
problems,” “slight problems,” “moderate problems,” “severe problems,” to “unable.” The 
second part, termed the ‘Your health today’ Visual Analogue Scale (VAS), comprises a picture 
of a thermometer with a scale ranging from 0 (worst) to 100 (best), and respondents mark 
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whereabouts on this scale they perceive their health to be on that day. Scores are converted to 
a percentage, where high scores represent the best health imaginable (van Hout et al., 2012). 
Responses on the ‘Descriptive System’ are considered to be health states, which are converted 
to a single index value, and interpreted as follows: 0=dead; 1=full health; and <0=worse than 
death (van Hout et al., 2012). The EQ-5D-5L is valid for stroke survivors (Golicki et al., 2015), 
and showed good internal consistency in our study (Cronbach alpha α=0.84).  
ICF Impairments: Mood 
Post-stroke mood was measured using the Patient Health Questionnaire (PHQ)-9. PHQ-
9 includes nine items measuring the frequency of depressive symptomatology, according to 
nine of the main criteria for major depressive disorder defined by the American Psychiatric 
Association Diagnostic and Statistical Manual (DSM) (Kroenke et al., 2001). Respondents 
recall over a period of two-weeks, the frequency with which they have been bothered by various 
symptoms (e.g., “Little interest or pleasure in doing things”). Possible responses were “Not at 
all,” “Several days,” “More than half the days,” to “Nearly every day.” A total PHQ-9 score 
was obtained by summing scores on the individual items (Kroenke et al., 2001). High scores 
indicated a greater severity of depressive symptomatology. PHQ-9 has recently been advocated 
as a promising approach for measuring mood amongst stroke survivors (Meader et al., 2013). 
Internal consistency was good in the present study (α=0.72).  
ICF Activities: Disability 
The Nottingham Extended Activities of Daily Living Scale provided a stroke-specific 
measure of instrumental activities of daily living after stroke (i.e., disability) (Nouri and 
Lincoln, 1987). It comprises 22-items covering everyday activities that respondents have 
performed in the ‘last few weeks’ (e.g., ‘walk around outside,’ ‘climb stairs’ etc.) Possible 
responses were “Not at all,” “With help,” “On your own with difficulty,” to “On your own.” A 
total score was obtained by summing scores on the individual items, where high scores 
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represent greater independence/recovery from post-stroke disability (Nouri and Lincoln, 1987). 
This instrument is valid and reliable for stroke survivors (Nouri and Lincoln, 1987), and had 
good internal consistency in our study (α=0.93).  
Illness Beliefs 
Illness beliefs were assessed using a stroke-specific version of the IPQ-R (Stroke IPQ-
R) (Aujla et al., In Press). This measures nine domains of illness beliefs. Twenty-one items 
assessed illness identity. Yes/no responses for each item (e.g., ‘Weakness or paralysis in arm 
or leg’) were summed to obtain a total score for stroke-related symptom burden. Sixty-six items 
assessed the remainder of domains (timeline acute-chronic, consequences, timeline-cyclical, 
personal control, treatment control, illness coherence, emotional representations and causal 
beliefs). Possible responses were “strongly disagree,” “disagree,” “I don’t know,” “agree,” and 
“strongly agree” (Moss-Morris et al., 2002). ‘The effects of my stroke will last for a short time’ 
is an example question for the timeline acute-chronic domain. The remainder of questions are 
summarised in Aujla et al. (In Press). Scores for each sub-scale were generated by summating 
the scores for individual items. Items with negative wording were reversed. High scores on the 
illness identity, timeline acute-chronic, timeline-cyclical, consequences, and emotional 
representations sub-scales indicated more negative beliefs about stroke, while those on the 
personal control, treatment control, and illness coherence sub-scales represented more positive 
beliefs (Moss-Morris et al., 2002). Internal consistency for all except the treatment control sub-
scale (α=0.42) was good (α≥0.77) in our study. 
Statistical Analysis 
The primary outcome was three-month post-stroke HRQL – arguably the best way to 
elicit how well survivors are recovering from the perspective of patients themselves 
(Deshpande et al., 2011). The secondary outcomes were mood and disability. Sample size was 
informed by findings from existing CSM stroke studies (e.g., O'Carroll et al. (2011); and 
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Twiddy et al. (2012)). Based on detecting a correlation of 0.4 between illness beliefs and 
markers of post-stroke recovery (e.g., mood); power=80%; alpha=0.05; and 20% attrition, we 
calculated a minimum sample of 55 participants.  
The analyses were conducted in STATA 13 (StataCorp LP, College Station, TX, USA). 
In view of our low participant numbers, our analyses should be considered exploratory. 
Statistical significance was assessed at the 5% level (p<0.05). A Bonferroni adjustment 
corrected for multiple testing. We assessed normality using histograms and skewness/kurtosis 
tests. Logarithmic (base 10) transformations were attempted for skewed variables, without 
fruition. The mean and standard deviation (or where data were non-normal, median and 
interquartile range) were calculated for all continuous variables, and frequency/percentages for 
categorical variables. A series of non-parametric Wilcoxon signed rank tests (or parametric 
paired sample t-tests for normal data) examined differences in our outcomes between baseline 
and follow-up. 
The remaining analyses were undertaken in two stages. Causal beliefs (16 separate 
attributions) were excluded in view of our modest sample size. First, we performed hierarchical 
agglomerative cluster analysis; the optimal method for clustering illness beliefs data 
(Clatworthy et al., 2007). Illness belief scores were standardised to Z-scores prior to clustering 
to ensure that all IPQ-R sub-scale scores had equal weight (Clatworthy et al., 2007). Clusters 
were formed based on similarities between participants on scores for each IPQ-R sub-scale, 
which were assessed using the Euclidean distance (i.e., the actual distance between two points 
if measured with a ruler). The optimum number of clusters was visually determined on a 
dendrogram (hierarchical tree-like structure). Clusters were combined using Ward’s method; 
the most common linkage rule used for illness beliefs data (Clatworthy et al., 2007). 
Participants were subsequently partitioned into ‘k’ clusters using k-medians; a partitioning 
method suitable for non-normal data. Cluster characteristics were summarised using the 
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mean/standard deviation (or median/interquartile range for non-normal data). A series of one-
way Analysis of Variance (ANOVA) plus Scheffe post-hoc comparisons (or Kruskal Wallis 
for non-normal variables) examined between-cluster differences.  
Second, multiple linear regression models were fitted. Socio-demographic and clinical 
variables were selected based on prior evidence. The analysis initially examined individual 
illness belief domains (not schema).  The order of entry was socio-demographic variables at 
the first step; clinical variables at the second step; and illness beliefs at the third step, as per 
O'Carroll et al. (2011). Models were compared using the change in R2 and likelihood ratio test, 
which provided a Chi-squared p-value to assess the statistical significance of variables added 
at each step. The analyses were subsequently repeated using clusters (step 4). 
 
Results 
Descriptive Analyses 
Our analyses used complete cases. Following Bonferroni adjustment, neither HRQL, 
mood nor disability differed significantly between baseline and follow-up (Appendix Table A). 
In terms of illness beliefs, participants reported few symptoms of their stroke at baseline and 
significantly fewer at follow-up (p<0.001). The majority perceived their stroke to be chronic, 
with fluctuating effects, greatly impacting upon their lives, and causing considerable distress. 
Most participants believed in their own ability and that of their treatment to control the effects 
of their stroke, though seemed to have an unsatisfactory understanding of their stroke. 
Participants tended to attribute their stroke to ‘Ageing’ or ‘Chance or bad luck’ rather than 
many of the modifiable risk factors for stroke (e.g., ‘High cholesterol,’ and ‘High blood 
pressure.’) 
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Identification of Illness Belief Schema 
 Three clusters emerged (see Appendix Figure A), that were named as follows: Cluster 1 
– ‘Low Adjusters;’ Cluster 2 – ‘Moderate Adjusters;’ and Cluster 3 – ‘High Adjusters’. Each 
cluster was characterised by specific illness belief schema (Appendix Table B). ‘Low 
Adjusters’ perceived their stroke to be chronic, with fluctuating effects, associated with a lot 
of symptoms, serious consequences and considerable distress. ‘Moderate Adjusters’ also 
perceived their stroke to be chronic, with serious consequences, associated with some 
symptoms and distress, but believed their stroke had non-fluctuating effects. ‘High Adjusters’ 
perceived their stroke as an acute condition with non-fluctuating effects, associated with few 
symptoms, less serious consequences, and little distress. All participants strongly believed in 
their own ability (personal control) and that of their treatment (treatment control) to control the 
effects of their stroke, but had a less than satisfactory understanding of stroke (illness 
coherence). Despite statistical non-significance, these domains were retained in the schema 
characterising each group of stroke survivors. 
The demographic and clinical characteristics of participants within each cluster are 
summarised in Appendix Table C. Three non-statistically significant trends were identified. 
First, ‘High Adjusters’ were older (mean=72.1, SD=15.1) than ‘Moderate Adjusters’ 
(mean=69.5, SD=12.3) and ‘Low Adjusters’ (mean=57.2, SD=13.5). Second, ‘High Adjusters’ 
were more likely to be retired; university educated; have a history of stroke or transient 
ischaemic attack; and a first-degree relative with stroke. Third, ‘Low Adjusters’ were more 
likely to have had a severe stroke; history of depression/anxiety; be an ex-smoker; drink more 
alcohol; and exercise less. ‘Low Adjusters’ were also more likely to have worse HRQL, mood, 
and disability compared to the other clusters. 
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Prediction of Post-Stroke Recovery: Individual versus Illness Belief Schema 
Findings from the multiple linear regression models for each outcome are reported in this 
section and summarised in Table 1 The primary outcome, HRQL, will be considered first. 
HRQL 
Baseline socio-demographic and clinical variables significantly explained 51.4% of the 
overall variance in three-month EQ-5D-5L Descriptive System – Index score and EQ-5D-5L 
‘Your health today’ VAS score. When individual illness beliefs were entered, none emerged 
as significant independent predictors of HRQL. However, when examining the change in R2, 
individual illness beliefs significantly explained a further 17.5% of the overall variance in 
three-month EQ-5D-5L Descriptive System – Index score, over and above that explained by 
baseline socio-demographic and clinical variables. When illness belief schema were entered, 
none of the clusters independently predicted HRQL. Inclusion of clusters in the model 
significantly explained only a further 0.60% and 5.7% of the overall variance in three-month 
EQ-5D-5L Descriptive System – Index score and  ‘Your health today’ VAS score 
(respectively), over and above that explained by baseline socio-demographic and clinical 
variable. 
Mood 
Baseline socio-demographic and clinical variables significantly explained 47.7% of the 
overall variance in three-month post-stroke mood. When individual illness beliefs were 
entered, only timeline-cyclical beliefs were a significant independent predictor of mood 
(β=0.71, 95%CI=0.08-1.34), controlling for socio-demographic and clinical variables. When 
illness belief schema were entered, ‘Moderate Adjusters’ had significantly better mood at three-
months than ‘Low Adjusters’ (β=-4.74, 95%CI=-9.31-(-0.17)). In examining the change in R2, 
individual versus illness belief schema significantly explained an additional 22.8% and 9.9% 
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of the overall variance in three-month mood, respectively, over and above that explained by 
baseline socio-demographic and clinical variables (Table 3). 
Disability 
Baseline socio-demographic and clinical variables significantly explained 79.8% of the 
overall variance in our other secondary outcome, three-month post-stroke disability. Neither 
individual nor illness belief schema significantly predicted post-stroke disability. When 
examining the change in R2, individual versus illness belief schema significantly explained 
only an additional 7.4% and 1.9% of the overall variance in three-month disability, 
respectively, over and above that explained by baseline socio-demographic and clinical 
variables. 
 
Discussion 
Our study identified three distinct illness belief schema: ‘Low Adjusters;’ ‘Moderate 
Adjusters;’ and ‘High Adjusters.’ In contrast to ‘High Adjusters’, ‘Low Adjusters’ perceived 
their stroke to be chronic, with fluctuating effects, associated with a lot of symptoms, serious 
consequences and considerable distress. We showed that when individual illness beliefs were 
examined in a series of multiple linear regression models, they significantly explained more of 
the variance in three-month post-stroke recovery (HRQL, mood and disability) than illness 
belief schema, over and above that explained by baseline socio-demographics and clinical 
variables.  
The evidence to date has consistently shown that individual and illness belief schema 
predict coping/treatment adherence and recovery in a range of conditions, including stroke 
(Hagger and Orbell, 2003, Twiddy et al., 2012, Medley et al., 2010, Snell et al., 2014, Lin and 
Heidrich, 2012). Our findings supported this premise. We too found that timeline-cyclical 
beliefs significantly predict mood three-months after stroke (consistent with Twiddy et al. 
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(2012)), and that post-stroke mood is significantly better amongst ‘Moderate’ than ‘Low 
Adjusters’ (consistent with Snell et al. (2014)). Our schema also comprised many of the illness 
beliefs (i.e., identity, chronicity, and consequence beliefs, and emotional representations) that 
have emerged in prior studies. 
However, unlike earlier papers (e.g., Medley et al. (2010)), we did not find a statistically 
significant role for personal and treatment control beliefs in any of our clusters. Nor did these 
domains significantly predict post-stroke HRQL, mood or disability. There may be three 
reasons for these findings. First, our participants generally demonstrated strong personal and 
treatment control beliefs (i.e., ceiling effect). Second, the treatment control sub-scale of the 
Stroke IPQ-R had poor internal consistency. Third, the study was limited by a modest sample 
size, meaning a high risk of Type 2 error. 
Nonetheless, our study is the first to show that there are differences in the amount of 
variability in post-stroke recovery explained by individual versus illness belief schema. This 
analysis was of theoretical relevance given the literature on inter-relatedness of illness beliefs 
(Hagger and Orbell, 2003, Hagger et al., 2017); existence of illness belief schema (Leventhal 
et al., 1980); and growing interest in the use of cluster analysis to examine whether illness 
belief schema predict outcomes. However, given that the traditional approach to analysing 
illness beliefs has been to consider them individually (i.e., the same manner in which they have 
been measured), it was important to formally examine which approach most usefully predicts 
outcomes. Contrary to earlier findings by Skinner et al. (2011), our study showed that if the 
amount of variability explained by these two approaches is the only consideration, individual 
illness beliefs have the potential to outperform illness belief schema in the prediction of post-
stroke outcomes. 
Three notable problems exist with our analysis. The first is sample size, which limited 
statistical power. A second issue is generalisability of our findings. There is a need for further 
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research to be undertaken with larger and more diverse samples of stroke survivors. As illness 
belief schema are different for different illnesses, comparable work in other conditions should 
also be carried out to see if consistent findings emerge. The third relates to the cluster analysis 
approach, which is inherently a data reduction technique. However, dichotomising data in this 
way is likely to result in a loss of sensitivity (Skinner et al., 2011). Therefore, it is unsurprising 
that less of the variability in outcomes was explained by clusters rather than individual illness 
beliefs. Other, more sensitive, ways of analysing these data (currently unknown) are worth 
exploring in future research.  
It is apparent though, at least in the context of stroke, that non-modifiable clinical 
variables still explain the largest amount of variability in post-stroke recovery (Lazar and 
Antoniello, 2008). However, the fact that our study showed that illness beliefs (individual or 
schema) explain even small to moderate amounts of variability in post-stroke recovery, 
suggests that there is still scope to intervene and modify maladaptive beliefs to improve 
outcomes. As has been considered in belief-based intervention studies to date (e.g., O'Carroll 
et al. (2013)). 
Strengths and Limitations 
A strength of our work is that it is the first to examine whether individual or illness belief 
schema differ in their prediction of post-stroke recovery. In addition, our study was conducted 
rigorously; employed validated instruments (e.g., EQ-5D-5L); measured multiple aspects of 
post-stroke recovery, as recommended by the ICF framework; and utilised robust statistical 
methods.  
Despite these strengths, our sample size was modest. This limited statistical power and 
means that our results should be interpreted cautiously. In addition, our sample comprised 
individuals with a non-severe stroke, mild residual disability and strong personal and treatment 
control beliefs, which may be non-representative of survivors in the acute phase of stroke. This 
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issue has also affected prior CSM stroke studies. Therefore, we recommend that future 
researchers examine ways in which a more diverse and representative sample of stroke 
survivors can be engaged in illness belief studies moving forward. 
Implications and Conclusion 
We have demonstrated that individual versus illness belief schema differ in the amount 
of variability in post-stroke recovery explained. However, we cannot advocate which is the 
best approach for dealing with illness beliefs data henceforth. This remains an unanswered but 
important question to clarify as it could help to shape the way in which future belief-based 
interventions are developed (i.e., continue addressing individual maladaptive illness beliefs or 
begin dealing more holistically with maladaptive illness belief schema). 
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Table 1. Summary of goodness of fit statistics for HRQL, Mood and Disability at each model step in  
 HRQL  
(EQ-5D-5L Descriptive 
System Index Score) 
HRQL  
(EQ-5D-5L ‘Your 
health today’ VAS 
Score) 
Mood  
(PHQ-9 Score) 
Disability 
(Nottingham Extended 
Activities of Daily 
Living Scale Score) 
 Total R2 
for the 
Model 
Change in 
R2 for the 
Step  (P-
value**) 
Total R2 
for the 
Model 
Change in 
R2 for the 
Step  (P-
value**) 
Total R2 
for the 
Model 
Change in 
R2 for the 
Step  (P-
value**) 
Total R2 
for the 
Model 
Change in 
R2 for the 
Step  (P-
value**) 
STEP 1: Addition of Socio-Demographic Variables 
+ Age  
+ Gender 
+ Deprivation 
 
0.073 
 
0.073 
(p=0.39) 
 
0.055 
 
0.055 
(p=0.52) 
 
0.068 
 
0.068 
(p=0.44) 
 
0.149 
 
0.149 
(p=0.09) 
STEP 2: Addition of Clinical Variables 
+ Co-morbidities 
+ National Institute of Health Stroke Scale score 
+ Baseline EQ-5D-5L Descriptive System- Index score 
+ Baseline EQ-5D-5L ‘Your health today’ VAS score 
+ Baseline PHQ-9 score 
+ Baseline Modified Rankin Scale score 
+ Baseline Barthel Index score 
+ Baseline Nottingham Extended Activities of Daily Living Scale score 
 
0.514 
 
0.441 
(p=0.009) 
 
0.514 
 
0.459 
(p=0.007) 
 
0.477 
 
0.409 
(p=0.02) 
 
0.798 
 
0.649 
(p=0.000) 
STEP 3: Addition of Individual Illness Belief Variables 
+ Identity 
+ Timeline acute-chronic 
+ Timeline cyclical 
+ Consequences 
+ Personal control 
+ Treatment control 
+ Illness coherence 
+ Emotional representations 
 
0.689 
 
0.175 
(p=0.003) 
 
0.590 
 
0.076 
(p=0.04) 
 
0.705 
 
0.228 
(p=0.002) 
 
0.872 
 
0.074 
(p=0.000) 
STEP 4: Addition of Illness Belief Schema Variables 
+ Moderate Adjusters*** 
+ High Adjusters*** 
 
0.520 
 
0.006 
(p=0.01) 
 
0.571 
 
0.057 
(p=0.004) 
 
0.576 
 
0.099 
(p=0.02) 
 
0.817 
 
0.019 
(p=0.000) 
Symbols and abbreviations: *: Bonferroni-adjusted significance level (p<0.002); **: Bonferroni-adjusted significance level (p<0.02); ***: Compared to Low Adjusters group; 
: Likelihood ratio test; CI: Confidence interval; HRQL; Health-Related Quality of Life; PHQ-9: Patient Health Questionnaire-9; VAS: Visual Analogue Scale. 
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APPENDIX 
 
Table A. Descriptive statistics, and differences between, baseline and three-month HRQL, mood, disability 
and illness belief scores 
 N 
Median (IQR), unless otherwise stated 
Z, unless 
otherwise stated 
P-value*  Baseline Follow-up 
HRQL 
EQ-5D-5L Descriptive System- Index 
score 
N=46 
0.74 (0.44) 
N=42 
0.77 (0.28) 
z=-2.84 
p=<0.01 
EQ-5D-5L ‘Your health today’ VAS 
score 
N=46 
58.3 (22.7) 
N=42 
70 (30) 
z=-2.05 
p=0.04 
Mood     
PHQ-9 Total depressive symptomatology 
score 
N=45 
6 (6) 
N=41 
4 (3) 
z=3.22 
p<0.01 
Disability    
Nottingham Extended Activities of Daily 
Living Scale score  
N=46 
17 (9) 
N=42 
17 (7) 
z=-1.81 
p=0.07 
Illness Beliefs 
Identity  N=42 z=3.83 
p<.0.001 9 (7) 7 (8) 
Timeline acute-chronic  N=42 -2.34 
p=0.02 Mean=15.4 
(SD=4.2) 
16 (8) 
Timeline-cyclical  N=42 z=2.72 
p<0.01 10 (6) 8 (4) 
Consequences  N=42 t=1.91 
p=0.06 Mean=30.8 
(SD=6.5) 
Mean=29.8 
(SD=5.3) 
Personal control  N=42 z=-0.97 
p=0.33 Mean=32.7 
(SD=4.4) 
34 (3) 
Treatment control  N=42 z=0.57 
p=0.57 20 (2) 20 (3) 
Illness coherence  N=42 z=-0.97 
p=0.33 19 (4) 19.5 (4) 
Emotional representations  N=42 z=2.57 
p<0.01 24 (7) 22 (8) 
Cause 1: Stress or worry, including 
family problems  
N=42 z=0.34 
p=0.73 3 (2) 3 (2) 
Cause 2: Heredity – it runs in my family N=42 z=0.15 
p=0.88 2 (0) 2 (1) 
Cause 3: Diet or eating habits N=42 z=1.32 
p=0.18 2 (2) 3 (2) 
Cause 4: Poor medical care in my past N=42 z=-0.37 
p=0.71 2 (0) 2 (2) 
Cause 5: My mental attitude e.g., 
thinking about life negatively 
N=42 z=0.14 
p=0.89 2 (0) 2 (0) 
Cause 6: Overwork N=42 z=0.49 
p=0.63 2 (2) 2 (2) 
Cause 7: My emotional state e.g., feeling 
down, lonely, anxious, empty 
N=42 z=-0.63 
p=0.53 2 (0) 
 
 
2 (0) 
Cause 8: Ageing N=42 z=-1.38 
p=0.17 4 (2) 4 (2) 
Cause 9: Alcohol N=42 z=0.53 
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2 (0) 2 (0) p=0.60 
Cause 10: Smoking N=42 z=-0.37 
p=0.71 2 (2) 2 (2) 
Cause 11: High cholesterol 
 
 
N=42 z=-2.01 
p<0.05 
3 (2) 3 (2) 
Cause 12: High blood pressure N=42 z=0.01 
p=0.99 3 (2) 3.5 (2) 
Cause 13: Diabetes N=42 z=-0.38 
p=0.71 2 (0) 2 (0) 
Cause 14: Problems with my heart, such 
as an irregular heartbeat 
N=42 z=-0.91 
p=0.36 
2 (0) 2 (2) 
Cause 15: Chance or bad luck N=42 z=0.22 
p=0.83 4 (2) 4 (2) 
Cause 16: Not taking enough exercise N=42 z=0.33 
p=0.75 2 (2) 2 (2) 
Symbols and abbreviations: *: Bonferroni-adjusted significance level (p<0.002); HRQL: Health-Related Quality 
of Life; IQR: Interquartile range; PHQ-9: Patient Health Questionnaire-9; SD: Standard deviation; VAS: Visual 
Analogue Scale 
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Table B. Descriptive statistics for illness belief scores, including between-cluster differences, split according 
to ‘Low,’ ‘Moderate’ and ‘High’ Adjuster groups 
 N 
Median belief scores (IQR) 
Illness beliefs  Cluster 1: 
‘Low 
adjusters’ 
N=13 
Cluster 2: 
‘Moderate 
adjusters’ 
N=11 
Cluster 3: 
‘High 
adjusters’ 
N=20 
Chi-
squared 
(DF) 
P-
value* 
Identity  14 (5) 9 (3) 4 (5) 29.0 (2) <.001 
Timeline acute-chronic  18 (6) 17 (8) 12 (3.5) 16.5 (2) <.001 
Timeline-cyclical  16 (2) 8 (0) 8 (2) 30.2 (2) <.001 
Consequences  37 (4) 34 (8) 25 (4) 30.1 (2) <.001 
Personal control  34 (5) 32 (2) 34 (5) 3.7 (2) 0.16 
Treatment control  18 (3) 20 (1) 20 (2) 4.1 (2) 0.13 
Illness coherence  19 (4) 20 (2) 18 (6) 1.8 (2) 0.41 
Emotional 
representations 
32 (7) 24 (10) 22 (5) 19.8 (2) <.001 
Symbols and abbreviations: *: Bonferroni adjusted significance level (p<0.002); DF: Degrees of freedom; IQR: 
Interquartile range 
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Table C. Summary of the baseline participant characteristics for each cluster 
 N 
Mean (SD)/Frequency (%), unless otherwise stated 
  
 
 
Demographics 
Cluster 1: ‘Low 
adjusters’ 
N=13 
Cluster 2: ‘Moderate 
adjusters’ 
N=11 
Cluster 3: ‘High 
adjusters’ 
N=20 
F (DF), unless 
otherwise 
stated 
P-value* 
Age 57.2 (13.5) 69.5 (12.3) 72.1 (15.1) 4.66 (2) <0.05 
Sex-Male 11 (84.6%) 7 (63.6%) 12 (60.0%) Chi2=2.34 
(DF=2) 
0.31 
University or higher education  2 (16.7%) 3 (27.3%) 4 (21.1%) Chi2=0.39 
(DF=2) 
0.82 
Employment status  
Unemployed 
Employed full-time 
Employed part-time 
Self-employed 
Retired 
 
4 (30.8%) 
3 (23.1%) 
1 (7.7%) 
1 (7.7%) 
4 (30.8%) 
 
1 (9.1%) 
1 (9.1%) 
2 (18.2%) 
1 (9.1%) 
6 (54.6%) 
 
1 (5.0%) 
2 (10.0%) 
0 (0%) 
3 (15.0%) 
14 (70.0%) 
 
Chi2=11.39 
(DF=8) 
 
0.12 
Index of Multiple Deprivation rank Median=16401 
(IQR=17730) 
Median=21243 
(IQR=19183) 
Median=20835 
(IQR=15764) 
Chi2=1.16 
(DF=2) 
0.56 
Index of Multiple Deprivation decile Median=5 (IQR=6) Median=7 (IQR=6) Median=7 (IQR=5.5) Chi2=1.31 
(DF=2) 
0.52 
National Institute of Health Stroke 
Scale score  
Median=5 (IQR=10) Median=2 (IQR=1) Median=2 (IQR=4) Chi2=6.15 
(DF=2) 
<0.05 
Pre-morbid Modified Rankin Scale 
score 
Median=0 (IQR=0) Median=0 (IQR=1) Median=0 (IQR=0) Chi2=0.73 
(DF=2) 
0.69 
Modified Rankin Scale score Median=2 (IQR=1) Median=2 (IQR=1) Median=1 (IQR=1) Chi2=8.4 
(DF=2) 
<.05 
Barthel Index score  Median=20 (IQR=1) Median=20 (IQR=0) Median=20 (IQR=0) Chi2=0.9 
(DF=2) 
0.64 
Clinical data      
Systolic blood pressure (mm/HG) 137.7  (21.0) 157.4 (44.0) 150 (35.9) 1.01 0.37 
Diastolic blood pressure (mm/HG) 71.7 (18.3) 84.6 (22.2) 80.5 (21.5) 1.26 0.29 
Blood glucose (mmol/L) Median=6.4 (IQR=5.6) Median=7.3 (IQR=3.3) Median=6.3 (IQR=2) Chi2=0.82 
(DF=2) 
0.67 
Total cholesterol (mmol/L) 4.7 (1.4) 4.7 (1.0) 4.7 (1.5) 0.00 0.99 
HDL cholesterol (mmol/L) Median=1.1 (IQR=0.5) Median=1.2 (IQR=0.4) Median=1.4 (IQR=0.70) Chi2=1.20 
(DF=2) 
0.55 
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LDL cholesterol (mmol/L) Median=2.2 (IQR=1.5) Median=3.05 (IQR=1.5) Median=2.35 (IQR=2.1) Chi2=2.46 
(DF=2) 
0.29 
BMI (kg/m2) Median=29 (IQR=10.3) Median=24 (IQR=6) Median=25 (IQR=5) Chi2=1.33 
(DF=2) 
0.52 
Family history-first degree relative 
(mother, father, sibling) 
     
History of stroke 3 (23.1%) 4 (36.4%) 8 (40.0%) Chi2=1.04 
(DF=2) 
0.60 
History of TIA 1 (7.7%) 1 (9.1%) 1 (5.0%) Chi2=0.21 
(DF=2) 
0.90 
Medical history**      
First stroke  3 (23.1%) 3 (27.3%) 3 (15.0%) Chi2=0.73 
(DF=2) 
0.70 
Previous TIA 1 (7.7%) 2 (18.2%) 3 (15.0%) Chi2=0.61 
(DF=2) 
0.74 
History of hypertension 8 (61.5%) 4 (36.4%) 13 (65.0%) Chi2=2.54 
(DF=2) 
0.28 
History of atrial fibrillation 1 (7.7%) 5 (45.5%) 2 (10.0%) Chi2=7.36 
(DF=2) 
<0.05 
History of high cholesterol 6 (46.2%) 6 (54.6%) 8 (40.0%) Chi2=0.61 
(DF=2) 
0.74 
History of depression 6 (46.2%) 2 (19.2%) 2 (10.0%) Chi2=6.98 
(DF=4) 
0.14 
History of anxiety disorders 4 (30.8%) 1 (9.1%) 3 (15.0%) Chi2=2.13 
(DF=2) 
0.34 
Previous therapy 8 (61.5%) 4 (36.4%) 9 (45.0%) Chi2=1.62 
(DF=2) 
0.44 
Co-morbidities 9 (69.2%) 7 (63.6%) 16 (80.0%) Chi2=1.07 
(DF=2) 
0.59 
Lifestyle       
Current smoking status** 
Never smoked 
Ex-smoker 
Current smoker 
 
4 (30.8%) 
8 (61.5%) 
1 (7.7%) 
 
5 (45.5%) 
6 (54.6%) 
0 (0%) 
 
9 (45.0%) 
9 (45.0%) 
2 (10.0%) 
 
Chi2=1.95 
(DF=4) 
 
0.75 
Number smoked daily Median=20 (IQR=10) Median=17.5 
(IQR=17.5) 
Median=7.5(IQR=10) Chi2=3.64 
(DF=2) 
0.16 
Current alcohol intake (units/week)¥ Median=6 (IQR=10.2) Median=4 (IQR=21) Median=0.75(IQR=14) Chi2=1.04 
(DF=2) 
0.59 
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Symbols and abbreviations: *: Bonferroni adjusted significance level (p<0.002); **: Self-reported; ¥: Extracted from medical records; BMI: Body Mass Index; DF: Degrees of 
freedom; IQR: Interquartile range; HDL: High Density Lipoprotein; HRQL: Health-related quality of life; IQR: Interquartile range; LDL; Low Density Lipoprotein; Interquartile 
range; PHQ-9: Patient Health Questionnaire-9; SD: Standard deviation; VAS: Visual Analogue Scale 
 
 
 
 
 
Units of beer Median=3 (IQR=11.2) Median=0.25 (IQR=7) Median=0 (IQR=3) Chi2=2.79 
(DF=2) 
0.25 
Units of wine Median=0 (IQR=0) Median=0.25 (IQR=4) Median=0 (IQR=1.25) Chi2=4.15 
(DF=2) 
0.13 
Units of spirits Median=0 (IQR=0) Median=0 (IQR=0) Median=0 (IQR=0) Chi2=0.61 
(DF=2) 
0.74 
30-minutes of exercise x4 times a 
week 
10 (76.9%) 7 (63.6%) 17 (85.0%) Chi2=1.85 
(DF=2) 
0.40 
Low-fat diet 8 (61.5%) 6 (54.5%) 9 (45.0%) Chi2=0.89 
(DF=2) 
0.64 
Low-sugar diet 10 (76.9%) 7 (63.6%) 10 (50.0%) Chi2=2.44 
(DF=2) 
0.30 
Low-salt diet 10 (76.9%) 6 (60.0%) 12 (60.0%) Chi2=1.14 
(DF=2) 
0.57 
HRQL      
EQ-5D-5L Index score Median=0.68 (IQR=0.18) Median=0.77 
(IQR=0.20) 
Median=0.88 
(IQR=0.40) 
Chi2=5.5 
(DF=2) 
0.06 
EQ-5D-5L ‘Your health today’ VAS 
score 
Median=60 (IQR=20) Median=70 (IQR=20) Median=75 (IQR=20) Chi2=2.7 
(DF=2) 
0.26 
Mood      
PHQ-9 Total depressive 
symptomatology score 
Median=6 (IQR=5) Median=4 (IQR=5) Median=3 (IQR=5) Chi2=8.2 
(DF=2) 
<.05 
Disability       
Nottingham Extended Activities of 
Daily Living Scale score  
Median=15 (IQR=9) Median=17 (IQR=7) Median=17 (IQR=4) Chi2=1.8 
(DF=2) 
0.41 
